• Julie G Pilitsis, Anthony Burrows, Mary Linton Peters, Julie Sargent, Sing Chau Ng, and Jennifer F Tseng.
• Division of Neurosurgery, Albany Medical College, Albany, NY 12208, USA. pilitsj @ mail.amc.edu
• Stereotact Funct Neurosurg. 2012 Jan 1;90(1):25-9.

BackgroundRandomized controlled studies have shown deep brain stimulation (DBS) to be an effective treatment for Parkinson's disease (PD). Outside of large-center studies, little is known about trends in DBS use in the USA.ObjectivesWe employ the Nationwide Inpatient Sample to look at changes in DBS utilization over time.MethodsWe identified all individuals with PD (332.0) and essential tremor (ET) (333.1) who underwent DBS (02.93) from 1998 to 2007. We examined demographics, hospital status, comorbidities, and in-hospital systemic/technical complications. DBS patients from 2000 and 2007 were compared using χ(2) tests.ResultsPD patients from the 2007 sample who underwent DBS were older (p = 0.01). Both ET and PD patients had significantly more comorbidities in 2007 (p < 0.001). In-hospital complications decreased from 3.8 to 2.8%. DBS was performed in medium- or high-volume centers in 70% of cases in 2000 and in 50% in 2007. In all groups, a majority of cases (range 65-71%) underwent DBS at hospitals in the western and southern USA.ConclusionsPatients who underwent DBS in the 2007 sample were older and had more comorbidities than those in the 2000 sample; in-hospital complications remained low. Understanding trends in DBS is helpful in assessing how the technology is adopted and what relationships should be further explored.Copyright © 2011 S. Karger AG, Basel.

23 keywords...

hide…